Hepatitis C News and Research

Latest Hepatitis C News and Research

The ‘perfect storm’: Redirecting family planning funds could undercut STD fight

A Trump administration effort to shift family planning funding toward groups that may not provide comprehensive services and away from organizations that provide abortions could cripple other federal efforts to curb an explosion in sexually transmitted diseases, some public health officials fear.

12 Jun 2018

Changes to the immune system remain even after recovery from HCV infection, shows study

Changes to the immune system remain many years after a hepatitis C infection heals, a new study by researchers at Karolinska Institutet, Sweden, and Hannover Medical School, Germany, shows.

11 Jun 2018

Researchers develop flexible "Plug and Play" technology to protect against emerging diseases

Researchers from GeoVax have developed a flexible "Plug and Play" technology platform that delivers single-dose vaccines that fully protect against emerging infectious diseases such as Zika, Lassa fever, and Ebola.

11 Jun 2018

Study finds high insurance denial rates for life-saving hepatitis C drugs in the U.S.

The number of insurance denials for life-saving hepatitis C drugs among patients with both private and public insurers remains high across the United States, researchers from the Perelman School of Medicine at the University of Pennsylvania reported in a new study published in the journal Open Forum Infectious Diseases.

7 Jun 2018

Redaction of substance abuse data could result in long-term implications

Due to a change in federal regulation, from 2013-2017, the Centers for Medicare and Medicaid Services redacted any health care encounter that included a diagnosis or procedure code related to substance abuse from the Medicare and Medicaid identifiable files.

5 Jun 2018

Researchers gain new insights into hepatitis B virus

Researchers at the University of Delaware, working with colleagues at Indiana University, have gained new insights into the virus that causes hepatitis B -- a life-threatening and incurable infection that afflicts more than 250 million people worldwide.

4 Jun 2018

New mathematical model holds potential to improve treatment for Hepatitis C infection

The University of Surrey has created a new mathematical model that details how the Hepatitis C infection develops and behaves more accurately than previous models. This new model has the potential to improve treatment for the infection that affects 215,000 people in the United Kingdom.

30 May 2018

Drugmakers blamed for blocking generics have milked prices and cost U.S. billions

Makers of brand-name drugs called out by the Trump administration for potentially stalling generic competition have hiked their prices by double-digit percentages since 2012 and cost Medicare and Medicaid nearly $12 billion in 2016, a Kaiser Health News analysis has found.

23 May 2018

Study: Medical centers more willing to perform lung transplants for severe alcoholic hepatitis patients

Increasingly, liver transplant centers are changing a long-standing practice of delaying potentially life-saving liver transplantation for patients with severe alcoholic hepatitis until after they stopped drinking alcohol for six months, according to a new study scheduled for presentation at Digestive Disease Week® (DDW) 2018.

22 May 2018

Few parents use simple strategies to protect kids from food poisoning, reports study

No parent wants to come home from a picnic or restaurant with a little one whose stomachache turns into much worse.

21 May 2018

Researchers discover new disease mechanism in chronic tobacco smokers

Research published in the journal Clinical Science suggests that an immune signaling protein called interleukin-26 is increased among chronic smokers with lung disease and this involvement reveals disease mechanisms of interest for developing more effective therapy for these hard-to-treat patients.

21 May 2018

Scientists find how immune system helps to clear HBV infection after treatment interruption

Scientists from Karolinska Institutet and Hannover Medical School have published two studies that provide insights into how the immune system responds and helps to clear a hepatitis B infection after treatment interruption.

17 May 2018

Phase 1/2 study evaluates safety, tolerability of multiple-ascending doses of ARO-HBV in hepatitis B patients

Arrowhead Pharmaceuticals Inc. today announced that it has dosed the first 3 hepatitis B virus patients in the multiple-ascending dose portion of its ongoing Phase 1/2 study of ARO-HBV, the company's third generation subcutaneously administered RNA interference therapeutic being developed as a potentially curative therapy for patients with chronic HBV infection.

14 May 2018

Scientists recover DNA from the oldest viruses

Researchers have successfully recovered DNA from the oldest viruses that are known to have infected mankind. These earliest viruses were all strains of hepatitis B.

13 May 2018

Trump vows (again) to lower drug prices but skeptics doubt much will change

President Donald Trump, armed with the expertise of staff seasoned in the ways of the drug industry, unveiled his blueprint to address sky-high drug prices Friday afternoon, promising that increasing industry competition will help Americans save at the pharmacy counter.

11 May 2018

UTHealth experts reveal how everyone can make a difference in infection control

When it comes to the examination room at your health care clinic, you might think that avoiding catching the flu or other more deadly viruses is out of your hands, so to speak.

4 May 2018

Study: HCV-exposed infants not adequately screened, despite increased prevalence

Due to the opioid epidemic, hepatitis C virus is increasing among pregnant women, resulting in a greater risk of perinatal transmission and HCV infection among children.

2 May 2018

CU Anschutz Medical Campus receives NIH grant to speed up discovery of new treatments

The National Institutes of Health recently awarded $46.5 million to the University of Colorado Anschutz Medical Campus and its Colorado Clinical and Translational Sciences Institute, a research partnership designed to speed up development of new treatments to address the greatest health needs of Coloradans.

25 Apr 2018

Many European countries lack comprehensive policy to eliminate viral hepatitis

Many European countries lack a comprehensive policy to eliminate viral hepatitis as a major public health threat, according to a patient group-based survey implemented in 25 countries.

18 Apr 2018

Computer-based intervention to increase parents’ knowledge about HPV vaccination

It's been almost 30 years since Salt-N-Pepa implored Americans to set their puritanical misgivings aside and talk about sex, and yet we still struggle with the subject; that fact is abundantly clear when you consider national HPV vaccination rates.

16 Apr 2018

Hepatitis C News and Research

Latest Hepatitis C News and Research

The ‘perfect storm’: Redirecting family planning funds could undercut STD fight

Changes to the immune system remain even after recovery from HCV infection, shows study

Researchers develop flexible "Plug and Play" technology to protect against emerging diseases

Study finds high insurance denial rates for life-saving hepatitis C drugs in the U.S.

Redaction of substance abuse data could result in long-term implications

Researchers gain new insights into hepatitis B virus

New mathematical model holds potential to improve treatment for Hepatitis C infection

Drugmakers blamed for blocking generics have milked prices and cost U.S. billions

Study: Medical centers more willing to perform lung transplants for severe alcoholic hepatitis patients

Few parents use simple strategies to protect kids from food poisoning, reports study

Researchers discover new disease mechanism in chronic tobacco smokers

Scientists find how immune system helps to clear HBV infection after treatment interruption

Phase 1/2 study evaluates safety, tolerability of multiple-ascending doses of ARO-HBV in hepatitis B patients

Scientists recover DNA from the oldest viruses

Trump vows (again) to lower drug prices but skeptics doubt much will change

UTHealth experts reveal how everyone can make a difference in infection control

Study: HCV-exposed infants not adequately screened, despite increased prevalence

CU Anschutz Medical Campus receives NIH grant to speed up discovery of new treatments

Many European countries lack comprehensive policy to eliminate viral hepatitis

Computer-based intervention to increase parents’ knowledge about HPV vaccination

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Hepatitis C News and Research

Latest Hepatitis C News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in